Wu‐Chou Su
Researcher Next ID · RN-014321
Researcher · Medicine
National Cheng Kung University Hospital
, Taiwan
- Works count
- 662
- Citation count
- 38,506
- H-index
- 78
- i10-index
- 301
Research interests
Publications
Osimertinib in Untreated EGFR -Mutated Advanced Non–Small-Cell Lung Cancer
New England Journal of Medicine · 2017 · 10.1056/nejmoa1713137
AZD9291 in EGFR Inhibitor–Resistant Non–Small-Cell Lung Cancer
New England Journal of Medicine · 2015 · 10.1056/nejmoa1411817
Afatinib versus cisplatin-based chemotherapy for EGFR mutation-positive lung adenocarcinoma (LUX-Lung 3 and LUX-Lung 6): analysis of overall survival data from two randomised, phase 3 trials
The Lancet Oncology · 2015 · 10.1016/s1470-2045(14)71173-8
Phase III Study of Afatinib or Cisplatin Plus Pemetrexed in Patients With Metastatic Lung Adenocarcinoma With EGFR Mutations
Journal of Clinical Oncology · 2013 · 10.1200/jco.2012.44.2806
Afatinib versus placebo for patients with advanced, metastatic non-small-cell lung cancer after failure of erlotinib, gefitinib, or both, and one or two lines of chemotherapy (LUX-Lung 1): a phase 2b/3 randomised trial
The Lancet Oncology · 2012 · 10.1016/s1470-2045(12)70087-6
Current projects
No projects listed.